Literature DB >> 10378876

Regulation of VIP production and secretion by murine lymphocytes.

C Martinez1, M Delgado, C Abad, R P Gomariz, D Ganea, J Leceta.   

Abstract

Vasoactive intestinal peptide (VIP) is a neuropeptide present in the lymphoid microenvironment with a multiplicity of actions. Two sources for VIP have been described in the immune system, the terminals present in central and peripheral lymphoid organs and the immune cells. Although VIP is synthesized by lymphocytes, there is no evidence demonstrating that VIP is released, and which stimuli are able to induce VIP production and secretion. In this study, we demonstrated for the first time, that agents that mediate important immune functions, such as proliferation and antigenic stimulation (Con A, LPS, and anti-TCR antibody), inflammation (LPS, TNFalpha, IL-6 and IL-1beta) or apoptosis (dexamethasone) induce the production and release of VIP to the lymphoid microenvironment. We conclude that VIP is produced and secreted by lymphocytes and propose that during an immune response, the timely release of VIP within the lymphoid organs and peritoneum should influence the differentiation and/or downregulation of the ongoing response.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10378876     DOI: 10.1016/s0165-5728(98)00216-1

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  24 in total

1.  Administration of a vasoactive intestinal peptide antagonist enhances the autologous anti-leukemia T cell response in murine models of acute leukemia.

Authors:  Christopher T Petersen; Jian-Ming Li; Edmund K Waller
Journal:  Oncoimmunology       Date:  2017-03-16       Impact factor: 8.110

2.  Vasoactive intestinal peptide loss leads to impaired CNS parenchymal T-cell infiltration and resistance to experimental autoimmune encephalomyelitis.

Authors:  Catalina Abad; Yossan-Var Tan; Robert Lopez; Hiroko Nobuta; Hongmei Dong; Phu Phan; Ji-Ming Feng; Anthony T Campagnoni; James A Waschek
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-26       Impact factor: 11.205

Review 3.  Decoding the chemokine network that links leukocytes with decidual cells and the trophoblast during early implantation.

Authors:  Rosanna Ramhorst; Esteban Grasso; Daniel Paparini; Vanesa Hauk; Lucila Gallino; Guillermina Calo; Daiana Vota; Claudia Pérez Leirós
Journal:  Cell Adh Migr       Date:  2016-02-18       Impact factor: 3.405

4.  Vasoactive Intestinal Peptide Promotes Fracture Healing in Sympathectomized Mice.

Authors:  Liu Shi; Yang Liu; Zhengmeng Yang; Tianyi Wu; Hiu Tung Lo; Jia Xu; Jiajun Zhang; Weiping Lin; Jinfang Zhang; Lu Feng; Gang Li
Journal:  Calcif Tissue Int       Date:  2021-05-17       Impact factor: 4.333

5.  Functional splice variants of the type II G protein-coupled receptor (VPAC2) for vasoactive intestinal peptide in mouse and human lymphocytes.

Authors:  Allison L Miller; Deepti Verma; Carola Grinninger; Mei-Chuan Huang; Edward J Goetzl
Journal:  Ann N Y Acad Sci       Date:  2006-07       Impact factor: 5.691

6.  Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor.

Authors:  Carmen Martinez; Catalina Abad; Mario Delgado; Alicia Arranz; Maria G Juarranz; Nieves Rodriguez-Henche; Philippe Brabet; Javier Leceta; Rosa P Gomariz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

7.  Neuroimmune link in the mucosa of chronic gastritis with Helicobacter pylori infection.

Authors:  G Sipos; K Altdorfer; E Pongor; L P Chen; E Fehér
Journal:  Dig Dis Sci       Date:  2006-10       Impact factor: 3.199

8.  Differential signaling of T cell generation of IL-4 by wild-type and short-deletion variant of type 2 G protein-coupled receptor for vasoactive intestinal peptide (VPAC2).

Authors:  Mei-Chuan Huang; Allison L Miller; Wengang Wang; Yvonne Kong; Sudhir Paul; Edward J Goetzl
Journal:  J Immunol       Date:  2006-06-01       Impact factor: 5.422

9.  Nerve growth factor, neuropeptides and cutaneous nerves in atopic dermatitis.

Authors:  Abeer Hodeib; Zeinab Abd El-Samad; Hesham Hanafy; Amani Abd El-Latief; Amal El-Bendary; Azza Abu-Raya
Journal:  Indian J Dermatol       Date:  2010 Apr-Jun       Impact factor: 1.494

10.  Vasoactive intestinal Peptide inhaled agonists: potential role in respiratory therapeutics.

Authors:  Ag Mathioudakis; V Chatzimavridou-Grigoriadou; E Evangelopoulou; Ga Mathioudakis
Journal:  Hippokratia       Date:  2013-01       Impact factor: 0.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.